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Congenital chloride diarrhea (CCD) also known as “Darrow-gamble syndrome” was first described in 1945. It is a rare disorder of intestinal chloride reabsorption with 
autosomal recessive inheritance. There are only 2 case reports of 
this disease from India in the early 90’s. We present a neonate 
who was diagnosed to have CCD, currently on salt replacement 
therapy and with regular follow-up.
CLINICAL BRIEF
Our patient was a preterm baby girl born to a 21 year old mother. 
There was history of third degree consanguineous marriage. The 
first pregnancy was a preterm vaginal delivery with antenatally 
detected polyhydramnios and dilated bowel loops in the fetus. 
The baby succumbed to illness on the day 1 of life, without any 
evaluation. The second pregnancy was a medical termination, 
and the third was a spontaneous abortion at 3 months. This was 
her fourth pregnancy. She had no medical problems; however, 
her second-trimester ultrasound scans showed a similar picture 
of polyhydramnios (amniotic fluid index - 30) with persistent 
dilated bowel loops. In view of recurrence of similar antenatal 
ultrasound findings of polyhydramnios and dilated bowel 
loops, a possibility of cystic fibrosis, CCD, and ileal atresia was 
considered. Fluorescence in situ hybridization for aneuploidy (13, 
18, and 21 sex chromosomes) and karyotype from amniotic fluid 
was normal.
The neonate was born by normal vaginal delivery at 33 weeks 
of gestation with a birth weight of 2.720 kg. She was noticed to 
have flaky yellow vernix possibly due to in utero diarrhea. The 
abdomen appeared distended and tense; however, X-ray abdomen 
ruled out intestinal obstruction and she passed meconium by 6 h 
of life. Other systemic examination was normal. The baby was 
noticed to have watery diarrhea on day 2, initially mistaken for 
urine, as the diarrhea was very watery. By day 4, she had 20% 
weight loss and severe dehydration. She received IV correction 
for dehydration. Stool volume was replaced.
At this point, blood investigations showed sodium (Na+): 130, 
potassium (K+): 6, and chloride (Cl−): 90 (meq/l). Total/Direct 
bilirubin : 17.86/0.44 , Serum Creatinine 3.4, Blood Urea Nitrogen 
: 143 (mg/dl). ABG showed metabolic alkalosis. She continued to 
have ongoing watery stools. Investigations on day 6, Na+: 123, 
K+:5.15, Cl-: 78 (meq/l). Fecal chloride was 49 mmol/l. A working 
diagnosis of CCD was made, considering antenatal ultrasonography 
findings, sibling death with a similar picture, profound watery 
diarrhea, hypochloremia, hyponatremia, metabolic alkalosis, and 
elevated fecal Cl- levels. Targeted gene sequencing detected a 
homozygous missense variation in exon 3 of the SLC26A3 gene 
(chr7:107434271; A>G; Depth: 109×) that results in the amino acid 
substitution of arginine for tryptophan at codon 63 (p.Trp63Arg). 
The same variation was detected in heterozygous condition in 
the parents, indicating that they are asymptomatic carriers of the 
variant. This is a previously unreported variant in the causative 
gene, which confirmed the diagnosis.
In view of ongoing losses, NaCl, as table salt, and KCl, as 
potassium chloride syrup, were added to make up for the need 
for chloride 6–8 mmol/kg/day, once dyselectrolytemia was 
controlled. After dehydration was corrected, she was managed 
on direct breastfeeds+160 ml/kg/day and replacement of stool 
volume as palladai feeds.
At discharge, blood gas analysis and electrolytes were within 
normal limits. She continued to have ongoing watery diarhhoea 
but was gaining weight and passing urine adequately. She was 
discharged on breastfeeds and measured palladai feeds. The 
mother was educated regarding the signs of dehydration, the 
need of frequent follow-up, and regular blood tests. Currently, 
she is 11 months (CGA-9 months), weighs 9 kg, and on regular 
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follow-up. Her electrolytes were monitored weekly, then once in 
2 weeks, and now monthly, and doses of NaCl and KCl have been 
adjusted. She has watery stools but of lesser volumes.
DISCUSSION
CCD (online Mendelian inheritance in man 214700) is a rare 
disorder, reported first in Finland. Most of the 250 reported cases 
arise from Finland, Poland, and Arab countries [1]. It occurs due 
to mutations in the SLC26A3 gene which leads to a disorder of 
intestinal Cl-/HCO3 exchange at the brush border epithelium 
of ileum and is characterized by persistent chloride diarrhea. 
Onset of this illness is in utero, with watery diarrhea causing 
polyhydramnios and triggering preterm labor [2]. Prenatal 
ultrasonographic diagnosis has been described. Polyhydramnios 
and massively dilated bowel loops with normal appearance of 
stomach may suggest CCD rather than intestinal obstructive 
diseases.
CCD is characterized by lifelong watery, urine like diarrhea. 
These neonates pass soft watery stool resulting in significant weight 
loss and dehydration. They also develop a large and distended 
abdomen with visible bowel loops which sometimes results in a 
clinical suspicion of intestinal obstruction leading to a surgical 
exploration. Blood investigations show metabolic alkalosis, 
hypochloremia, hyponatremia, hypokalemia, hyperaldosteronism, 
and hyperreninemia [1]. Our neonate had all the above typical 
clinical and laboratory findings. Nephrocalcinosis and impaired 
renal function have been reported [3,4]. Wedenoja et al. showed 
that despite the protective renal effect of salt substitution 
during childhood, the incidence of renal injury in treated CCD 
is high [3]. Screening renal ultrasound of this neonate showed 
mildly echogenic kidneys.
Stool pH usually between 4 and 6 and fecal chloride content of 
>90 meq/l (when serum Cl- levels are normal) with typical clinical 
picture are diagnostic. Excessive volume and salt depletion reduce 
the amount of diarrhea and may result in a low fecal Cl- of even 
40 mmol/L, as is seen in our neonate when serum chloride was 
low [5]. Definitive diagnosis is by genetic tests. The basic defect of 
intestinal reabsorption has no definitive treatment. Initial treatment 
of fluid depletion and salt substitution therapy with NaCl and KCl 
forms the mainstay of treatment [6]. The optimal dose of chloride 
varies between 6 and 8 mmol/kg/day in neonates and smaller doses 
of 3–4 mmol/kg/day are sufficient in older infants to maintain 
normal serum Cl- levels [1,5,7,8]. Ketoprofen, omeprazole, oral 
butyrate, and cholestyramine have been tried [9,10], but our 
neonate had normal blood gases, electrolytes, and correction of 
dehydration with just salt and volume replacement.
CONCLUSION
Appropriate replacement therapy started in the neonatal period 
prevents fatal dyselectrolytemia and dehydration and enables 
normal physical and mental development in CCD.
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